Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
暂无分享,去创建一个
[1] I B Dawid,et al. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression , 1997, Molecular and cellular biology.
[2] R. Fletterick,et al. A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[3] K. Horwitz,et al. Nuclear receptor coactivators and corepressors. , 1996, Molecular endocrinology.
[4] M. Privalsky,et al. Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. , 1996, Molecular endocrinology.
[5] R. Evans,et al. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states , 1996, Molecular and cellular biology.
[6] P. Chambon,et al. TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. , 1996, The EMBO journal.
[7] M. Bagchi,et al. Ligand-dependent Cross-talk between Steroid and Thyroid Hormone Receptors , 1996, The Journal of Biological Chemistry.
[8] M. Stallcup,et al. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[9] Thorsten Heinzel,et al. A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.
[10] G. Tong,et al. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor , 1996, Molecular and cellular biology.
[11] S. Kersten,et al. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently. , 1996, Biochemistry.
[12] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[13] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[14] Mary E. McGrath,et al. A structural role for hormone in the thyroid hormone receptor , 1995, Nature.
[15] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.
[16] B. O’Malley,et al. Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.
[17] Myles Brown,et al. Polarity-specific activities of retinoic acid receptors determined by a co-repressor , 1995, Nature.
[18] Thorsten Heinzel,et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.
[19] R. Evans,et al. A transcriptional co-repressor that interacts with nuclear hormone receptors , 1995, Nature.
[20] P. Kushner,et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. , 1995, The EMBO journal.
[21] William Bourguet,et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.
[22] K. Umesono,et al. Unique response pathways are established by allosteric interactions among nuclear hormone receptors , 1995, Cell.
[23] G. Tong,et al. Ligand Modulates the Interaction of Thyroid Hormone Receptor with the Basal Transcription Machinery (*) , 1995, The Journal of Biological Chemistry.
[24] P. Chambon,et al. The N‐terminal part of TIF1, a putative mediator of the ligand‐dependent activation function (AF‐2) of nuclear receptors, is fused to B‐raf in the oncogenic protein T18. , 1995, The EMBO journal.
[25] D. Moore,et al. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator , 1995, Nature.
[26] R. Brent,et al. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. , 1995, Molecular endocrinology.
[27] B. O’Malley,et al. The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing , 1995, Molecular and cellular biology.
[28] C. Glass,et al. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding , 1994, Nature.
[29] B. Raaka,et al. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor , 1994, Molecular and cellular biology.
[30] D. Barettino,et al. Characterization of the ligand‐dependent transactivation domain of thyroid hormone receptor. , 1994, The EMBO journal.
[31] G. Martin,et al. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. , 1994, Science.
[32] B. O’Malley,et al. Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[33] J. Fondell,et al. Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. , 1993, Genes & development.
[34] C. Glass,et al. Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. , 1993, Genes & development.
[35] K. Umesono,et al. Determinants for selective RAR and TR recognition of direct repeat HREs. , 1993, Genes & development.
[36] M. Lazar. Thyroid hormone receptors: multiple forms, multiple possibilities. , 1993, Endocrine reviews.
[37] J. Baxter,et al. Thyroid hormone alters in vitro DNA binding of monomers and dimers of thyroid hormone receptors. , 1992, Molecular endocrinology.
[38] H. Gronemeyer,et al. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. , 1992, The Journal of biological chemistry.
[39] R. Renkawitz,et al. A transferable silencing domain is present in the thyroid hormone receptor, in the v‐erbA oncogene product and in the retinoic acid receptor. , 1992, The EMBO journal.
[40] J. Lees,et al. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.
[41] D. Darling,et al. Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor-auxiliary protein heterodimers. , 1992, The Journal of biological chemistry.
[42] K. Umesono,et al. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.
[43] Klaus Damm,et al. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist , 1989, Nature.
[44] P. Chambon,et al. Steroid hormone receptors compete for factors that mediate their enhancer function , 1989, Cell.
[45] William E. Paterson,et al. Federal Republic of Germany , 1985, International Journal of Comparative Labour Law and Industrial Relations.
[46] B. O’Malley,et al. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.